Clinical Trial Update: An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of epoetin alfa (PROCRIT) in cancer patients with anemia who are not receiving chemotherapy or radiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Neoplasms

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Neoplasms | Phase 3 | Status: COMPLETED